Vasu Divi1, Jonathan Harris2, Paul M Harari3, Jay S Cooper4, Jonathan McHugh5, Diana Bell6, Erich M Sturgis6, Anthony J Cmelak7, Mohan Suntharalingam8, David Raben9, Harold Kim10, Sharon A Spencer11, George E Laramore12, Andy Trotti13, Robert L Foote14, Christopher Schultz15, Wade L Thorstad16, Qiang Ed Zhang2, Quynh Thu Le1, F Christopher Holsinger1. 1. Stanford University, Stanford, California. 2. NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania. 3. University of Wisconsin, Madison, Wisconsin. 4. Maimonides Cancer Center, Brooklyn, New York. 5. University of Michigan, Ann Arbor, Michigan. 6. The University of Texas MD Anderson Cancer Center, Houston, Texas. 7. Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. 8. Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland. 9. University of Colorado Denver, Aurora, Colorado. 10. Academic Radiation Oncology, Wayne State University, Detroit, Michigan. 11. University of Alabama at Birmingham, Birmingham, Alabama. 12. University of Washington, Seattle, Washington. 13. H. Lee Moffitt Cancer Center, Tampa, Florida. 14. Mayo Clinic, Rochester, Minnesota. 15. Medical College of Wisconsin, Milwaukee, Wisconsin. 16. Washington University School of Medicine in St. Louis, St. Louis, Missouri.
Abstract
BACKGROUND: Prospective quality metrics for neck dissection have not been established for patients with head and neck squamous cell carcinoma. The purpose of this study was to investigate the association between lymph node counts from neck dissection, local-regional recurrence, and overall survival. METHODS: The number of lymph nodes counted from neck dissection in patients treated in 2 NRG Oncology trials (Radiation Therapy Oncology Group [RTOG] 9501 and RTOG 0234) was evaluated for its prognostic impact on overall survival with a multivariate Cox model adjusted for demographic, tumor, and lymph node data and stratified by the postoperative treatment group. RESULTS: Five hundred seventy-two patients were analyzed at a median follow-up of 8 years. Ninety-eight percent of the patients were pathologically N+. The median numbers of lymph nodes recorded on the left and right sides were 24 and 25, respectively. The identification of fewer than 18 nodes was associated with worse overall survival in comparison with 18 or more nodes (hazard ratio [HR], 1.38; 95% confidence interval [CI], 1.09-1.74; P = .007). The difference appeared to be driven by local-regional failure (HR, 1.46; 95% CI, 1.02-2.08; P = .04) but not by distant metastases (HR, 1.08; 95% CI, 0.77-1.53; P = .65). When the analysis was limited to NRG Oncology RTOG 0234 patients, adding the p16 status to the model did not affect the HR for dissected nodes, and the effect of nodes did not differ with the p16 status. CONCLUSIONS: The removal and identification of 18 or more lymph nodes was associated with improved overall survival and lower rates of local-regional failure, and this should be further evaluated as a measure of quality in neck dissections for mucosal squamous cell carcinoma. Cancer 2016;122:3464-71.
BACKGROUND: Prospective quality metrics for neck dissection have not been established for patients with head and neck squamous cell carcinoma. The purpose of this study was to investigate the association between lymph node counts from neck dissection, local-regional recurrence, and overall survival. METHODS: The number of lymph nodes counted from neck dissection in patients treated in 2 NRG Oncology trials (Radiation Therapy Oncology Group [RTOG] 9501 and RTOG 0234) was evaluated for its prognostic impact on overall survival with a multivariate Cox model adjusted for demographic, tumor, and lymph node data and stratified by the postoperative treatment group. RESULTS: Five hundred seventy-two patients were analyzed at a median follow-up of 8 years. Ninety-eight percent of the patients were pathologically N+. The median numbers of lymph nodes recorded on the left and right sides were 24 and 25, respectively. The identification of fewer than 18 nodes was associated with worse overall survival in comparison with 18 or more nodes (hazard ratio [HR], 1.38; 95% confidence interval [CI], 1.09-1.74; P = .007). The difference appeared to be driven by local-regional failure (HR, 1.46; 95% CI, 1.02-2.08; P = .04) but not by distant metastases (HR, 1.08; 95% CI, 0.77-1.53; P = .65). When the analysis was limited to NRG Oncology RTOG 0234 patients, adding the p16 status to the model did not affect the HR for dissected nodes, and the effect of nodes did not differ with the p16 status. CONCLUSIONS: The removal and identification of 18 or more lymph nodes was associated with improved overall survival and lower rates of local-regional failure, and this should be further evaluated as a measure of quality in neck dissections for mucosal squamous cell carcinoma. Cancer 2016;122:3464-71.
Authors: V E Lemmens; I van Lijnschoten; M L Janssen-Heijnen; H J Rutten; C D Verheij; J-W W Coebergh Journal: Ann Oncol Date: 2006-09-13 Impact factor: 32.976
Authors: Ardalan Ebrahimi; Jonathan R Clark; M Amit; T C Yen; Chun-Ta Liao; Luis P Kowalski; Matthias Kreppel; Claudio R Cernea; Gideon Bachar; Andrea Bolzoni Villaret; Dan Fliss; Eran Fridman; K T Robbins; Jatin P Shah; Snehal G Patel; Ziv Gil Journal: Ann Surg Oncol Date: 2014-04-14 Impact factor: 5.344
Authors: Paul M Harari; Jonathan Harris; Merrill S Kies; Jeffrey N Myers; Richard C Jordan; Maura L Gillison; Robert L Foote; Mitchell Machtay; Marvin Rotman; Deepak Khuntia; William Straube; Qiang Zhang; Kian Ang Journal: J Clin Oncol Date: 2014-07-07 Impact factor: 44.544
Authors: S G Patel; M Amit; T C Yen; C T Liao; P Chaturvedi; J P Agarwal; L P Kowalski; A Ebrahimi; J R Clark; C R Cernea; S J Brandao; M Kreppel; J Zöller; D Fliss; E Fridman; G Bachar; T Shpitzer; V A Bolzoni; P R Patel; S Jonnalagadda; K T Robbins; J P Shah; Z Gil Journal: Br J Cancer Date: 2013-09-24 Impact factor: 7.640
Authors: R Alex Harbison; Alan J Gray; Ted Westling; Marco Carone; Cristina P Rodriguez; Neal D Futran; Richard B Cannon; Jeffrey Houlton Journal: Laryngoscope Date: 2019-08-29 Impact factor: 3.325
Authors: Shlomo A Koyfman; Nofisat Ismaila; Doug Crook; Anil D'Cruz; Cristina P Rodriguez; David J Sher; Damian Silbermins; Erich M Sturgis; Terance T Tsue; Jared Weiss; Sue S Yom; F Christopher Holsinger Journal: J Clin Oncol Date: 2019-02-27 Impact factor: 44.544
Authors: Patrick Tassone; Corey Savard; Michael C Topf; William Keane; Adam Luginbuhl; Joseph Curry; David Cognetti Journal: JAMA Otolaryngol Head Neck Surg Date: 2018-11-01 Impact factor: 6.223
Authors: Jan Oliver Voss; Lea Freund; Felix Neumann; Friedrich Mrosk; Kerstin Rubarth; Kilian Kreutzer; Christian Doll; Max Heiland; Steffen Koerdt Journal: Clin Oral Investig Date: 2022-07-27 Impact factor: 3.606
Authors: David W Schoppy; Kim F Rhoads; Yifei Ma; Michelle M Chen; Brian Nussenbaum; Ryan K Orosco; Eben L Rosenthal; Vasu Divi Journal: JAMA Otolaryngol Head Neck Surg Date: 2017-11-01 Impact factor: 6.223
Authors: Robert L Ferris; Yael Flamand; F Christopher Holsinger; Gregory S Weinstein; Harry Quon; Ranee Mehra; Joaquin J Garcia; Michael L Hinni; Neil D Gross; Erich M Sturgis; Umamaheswar Duvvuri; Eduardo Méndez; John A Ridge; J Scott Magnuson; Kerry A Higgins; Mihir R Patel; Russel B Smith; Daniel W Karakla; Michael E Kupferman; James P Malone; Benjamin L Judson; Jeremy Richmon; Jay O Boyle; Rodrigo Bayon; Bert W O'Malley; Enver Ozer; Giovana R Thomas; Wayne M Koch; R Bryan Bell; Nabil F Saba; Shuli Li; Elin R Sigurdson; Barbara Burtness Journal: Oral Oncol Date: 2020-07-14 Impact factor: 5.337